JP2016188255A5 - - Google Patents

Download PDF

Info

Publication number
JP2016188255A5
JP2016188255A5 JP2016155625A JP2016155625A JP2016188255A5 JP 2016188255 A5 JP2016188255 A5 JP 2016188255A5 JP 2016155625 A JP2016155625 A JP 2016155625A JP 2016155625 A JP2016155625 A JP 2016155625A JP 2016188255 A5 JP2016188255 A5 JP 2016188255A5
Authority
JP
Japan
Prior art keywords
compound
reacting
manufacturing process
methanol
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016155625A
Other languages
English (en)
Japanese (ja)
Other versions
JP6275784B2 (ja
JP2016188255A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2016188255A publication Critical patent/JP2016188255A/ja
Publication of JP2016188255A5 publication Critical patent/JP2016188255A5/ja
Application granted granted Critical
Publication of JP6275784B2 publication Critical patent/JP6275784B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016155625A 2011-04-01 2016-08-08 亜鉛結合部分を有するホスホイノシチド3−キナーゼインヒビター Active JP6275784B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161470849P 2011-04-01 2011-04-01
US61/470,849 2011-04-01
US201161559489P 2011-11-14 2011-11-14
US61/559,489 2011-11-14

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2014502821A Division JP6242331B2 (ja) 2011-04-01 2012-03-30 亜鉛結合部分を有するホスホイノシチド3−キナーゼインヒビター

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018001910A Division JP2018052987A (ja) 2011-04-01 2018-01-10 亜鉛結合部分を有するホスホイノシチド3−キナーゼインヒビター

Publications (3)

Publication Number Publication Date
JP2016188255A JP2016188255A (ja) 2016-11-04
JP2016188255A5 true JP2016188255A5 (show.php) 2016-12-15
JP6275784B2 JP6275784B2 (ja) 2018-02-07

Family

ID=46931927

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2014502821A Active JP6242331B2 (ja) 2011-04-01 2012-03-30 亜鉛結合部分を有するホスホイノシチド3−キナーゼインヒビター
JP2016155625A Active JP6275784B2 (ja) 2011-04-01 2016-08-08 亜鉛結合部分を有するホスホイノシチド3−キナーゼインヒビター
JP2018001910A Withdrawn JP2018052987A (ja) 2011-04-01 2018-01-10 亜鉛結合部分を有するホスホイノシチド3−キナーゼインヒビター

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2014502821A Active JP6242331B2 (ja) 2011-04-01 2012-03-30 亜鉛結合部分を有するホスホイノシチド3−キナーゼインヒビター

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018001910A Withdrawn JP2018052987A (ja) 2011-04-01 2018-01-10 亜鉛結合部分を有するホスホイノシチド3−キナーゼインヒビター

Country Status (29)

Country Link
US (7) US8710219B2 (show.php)
EP (2) EP3111938B1 (show.php)
JP (3) JP6242331B2 (show.php)
KR (2) KR101902325B1 (show.php)
CN (2) CN105461736B (show.php)
AU (1) AU2012236367B2 (show.php)
BR (1) BR112013025340B1 (show.php)
CA (1) CA2830822C (show.php)
CL (1) CL2013002823A1 (show.php)
CY (2) CY1117785T1 (show.php)
DK (2) DK3111938T3 (show.php)
EA (1) EA022434B9 (show.php)
ES (2) ES2733128T3 (show.php)
HR (2) HRP20160545T1 (show.php)
HU (2) HUE045041T2 (show.php)
IL (2) IL228588A (show.php)
LT (1) LT3111938T (show.php)
ME (2) ME03523B (show.php)
MX (1) MX340577B (show.php)
PE (1) PE20141382A1 (show.php)
PL (2) PL2694075T3 (show.php)
PT (2) PT3111938T (show.php)
RS (2) RS59219B1 (show.php)
SG (2) SG10201602569RA (show.php)
SI (2) SI3111938T1 (show.php)
SM (2) SMT201900435T1 (show.php)
TW (1) TWI571469B (show.php)
WO (1) WO2012135571A1 (show.php)
ZA (2) ZA201307082B (show.php)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010203512C1 (en) 2009-01-08 2013-10-17 Curis, Inc. Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
SG10201602569RA (en) 2011-04-01 2016-05-30 Curis Inc Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
SG10201510307WA (en) 2011-11-14 2016-01-28 Cephalon Inc Uracil derivatives as axl and c-met kinase inhibitors
CN104725301A (zh) * 2013-12-20 2015-06-24 北京蓝贝望生物医药科技股份有限公司 一种1,2-二氢吡啶-2-酮衍生物的制备方法
JP6518833B2 (ja) * 2015-04-21 2019-05-22 ▲貴▼州百▲霊▼企▲業▼集▲団▼制▲薬▼股▲分▼有限公司Guizhou Bailing Group Pharmaceutical Co.,Ltd. プリニル−n−ヒドロキシルピリミジンホルムアミド誘導体、並びにその調製方法および使用
CN109476710B (zh) * 2016-07-19 2021-11-23 国立植物基因组研究所 抗真菌病原体的新蛋白质
WO2018085342A1 (en) * 2016-11-02 2018-05-11 Curis, Inc. Combination therapy with a phosphoinositide 3-kinase inhibitor with a zinc binding moiety
AU2018360845B2 (en) * 2017-11-06 2024-05-02 Cold Spring Harbor Laboratory Method and compositions for forming a copper-containing complex and uses thereof
MA53619A (fr) 2018-09-11 2021-12-15 Curis Inc Polythérapie avec un inhibiteur de phosphoinositide 3-kinase ayant une fraction de liaison au zinc
EP3968215A1 (en) 2020-09-09 2022-03-16 Koninklijke Philips N.V. Determining target object type and position
WO2023212574A1 (en) * 2022-04-26 2023-11-02 Olivia Szu Hsieh Lee Nakaya Compositions and methods for modulating rhythmic activity of pacemaker cardiomyocytes

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4828991A (en) 1984-01-31 1989-05-09 Akzo N.V. Tumor specific monoclonal antibodies
US5369108A (en) 1991-10-04 1994-11-29 Sloan-Kettering Institute For Cancer Research Potent inducers of terminal differentiation and methods of use thereof
US5502187A (en) 1992-04-03 1996-03-26 The Upjohn Company Pharmaceutically active bicyclic-heterocyclic amines
US5497763A (en) 1993-05-21 1996-03-12 Aradigm Corporation Disposable package for intrapulmonary delivery of aerosolized formulations
US5508269A (en) 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
US6777217B1 (en) 1996-03-26 2004-08-17 President And Fellows Of Harvard College Histone deacetylases, and uses related thereto
US6083922A (en) 1996-04-02 2000-07-04 Pathogenesis, Corp. Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis
US5767068A (en) 1997-02-13 1998-06-16 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
CN1186324C (zh) 2000-04-27 2005-01-26 山之内制药株式会社 稠合杂芳基衍生物
US6608053B2 (en) 2000-04-27 2003-08-19 Yamanouchi Pharmaceutical Co., Ltd. Fused heteroaryl derivatives
PL220783B1 (pl) 2002-03-13 2016-01-29 Janssen Pharmaceutica Nv Pochodna sulfonylowa, jej zastosowanie i sposób wytwarzania oraz kompozycja farmaceutyczna
ES2347544T3 (es) 2002-03-13 2010-11-02 Janssen Pharmaceutica Nv Inhibidores de histona-desacetilasas.
WO2003076395A1 (en) 2002-03-13 2003-09-18 Janssen Pharmaceutica N.V. Carbonylamino-derivatives as novel inhibitors of histone deacetylase
AU2003209727B2 (en) 2002-03-13 2008-10-16 Janssen Pharmaceutica N.V. Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
WO2004017950A2 (en) 2002-08-22 2004-03-04 Piramed Limited Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents
SI1591446T1 (sl) 2003-01-29 2013-07-31 Takeda Pharmaceutical Company Limited Tienopiridinske spojine in njihova uporaba
US8227636B2 (en) * 2004-04-05 2012-07-24 Merck Hdac Research, Llc Histone deacetylase inhibitor prodrugs
AU2005249380C1 (en) 2004-04-23 2012-09-20 Exelixis, Inc. Kinase modulators and methods of use
WO2006040966A1 (ja) 2004-10-08 2006-04-20 Astellas Pharma Inc. 芳香環縮合ピリミジン誘導体
GB0423653D0 (en) 2004-10-25 2004-11-24 Piramed Ltd Pharmaceutical compounds
EP2522396A1 (en) 2005-02-03 2012-11-14 TopoTarget UK Limited Combination therapies using HDAC inhibitors
EP1885710B1 (en) 2005-05-18 2015-08-19 Janssen Pharmaceutica N.V. Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase
US7888360B2 (en) 2006-01-19 2011-02-15 Janssen Pharmaceutica N.V. Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
JP5247470B2 (ja) 2006-01-19 2013-07-24 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ヒストンデアセチラーゼのインヒビターとしてのピリジン及びピリミジン誘導体
AU2007206941B2 (en) 2006-01-19 2012-09-13 Janssen Pharmaceutica N.V. Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase
EP2046799B1 (en) 2006-04-26 2017-07-19 Genentech, Inc. Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them
CA2650290C (en) 2006-04-26 2015-11-17 Genentech, Inc. Pharmaceutical compounds
PT2024372E (pt) 2006-04-26 2010-09-16 Hoffmann La Roche Derivado de tieno[3,2-d]pirimidina útil como inibidor de pi3k
WO2007131364A1 (en) 2006-05-16 2007-11-22 Mcgill University Hybrid molecules having mixed vitamin d receptor agonism and histone deacetylase inhibitory properties
US20080161320A1 (en) 2006-09-11 2008-07-03 Xiong Cai Fused bicyclic pyrimidines as ptk inhibitors containing a zinc binding moiety
CA2662617C (en) 2006-09-11 2014-11-18 Changgeng Qian Quinazoline based egfr inhibitors containing a zinc binding moiety
AU2007296744A1 (en) 2006-09-11 2008-03-20 Curis, Inc. Multi-functional small molecules as anti-proliferative agents
CA2663147A1 (en) 2006-09-11 2008-03-20 Curis, Inc. Substituted 2-indolinone as ptk inhibitors containing a zinc binding moiety
AU2007296743B2 (en) 2006-09-11 2012-02-16 Curis, Inc. Tyrosine kinase inhibitors containing a zinc binding moiety
US7547781B2 (en) 2006-09-11 2009-06-16 Curis, Inc. Quinazoline based EGFR inhibitors containing a zinc binding moiety
WO2008055068A2 (en) 2006-10-28 2008-05-08 Methylgene Inc. Inhibitors of histone deacetylase
RU2470936C2 (ru) 2006-12-07 2012-12-27 Дженентек, Инк. Соединения-ингибиторы фосфоинозитид 3-киназы и способы применения
MY180595A (en) 2006-12-07 2020-12-03 Genentech Inc Phosphoinositide 3-kinase inhibitor compounds and methods of use
BRPI0807812A2 (pt) 2007-02-15 2020-06-23 Novartis Ag Combinações de lbh589 com outros agentes terapêuticos para tratar câncer
EP2136809A4 (en) 2007-03-20 2012-01-04 Curis Inc INHIBITORS OF RAF KINASE CONTAINING A ZINC BINDING FRAGMENT
WO2009036057A1 (en) 2007-09-10 2009-03-19 Curis, Inc. Antiproliferative agents containing a zinc binding moiety
TW200922564A (en) 2007-09-10 2009-06-01 Curis Inc CDK inhibitors containing a zinc binding moiety
WO2009036066A1 (en) 2007-09-10 2009-03-19 Curis, Inc. Vegfr inhibitors containing a zinc binding moiety
WO2009036020A1 (en) 2007-09-10 2009-03-19 Curis, Inc. Mek inhibitors containing a zinc binding moiety
TW200922590A (en) 2007-09-10 2009-06-01 Curis Inc VEGFR inhibitors containing a zinc binding moiety
KR101584823B1 (ko) * 2007-09-12 2016-01-22 제넨테크, 인크. 포스포이노시타이드 3-키나제 저해제 화합물과 화학치료제의 배합물 및 이의 사용방법
WO2009042646A1 (en) 2007-09-24 2009-04-02 Curis, Inc. Anti-proliferative agents
CN101909631B (zh) * 2007-10-25 2012-09-12 健泰科生物技术公司 制备噻吩并嘧啶化合物的方法
US20090149511A1 (en) 2007-10-30 2009-06-11 Syndax Pharmaceuticals, Inc. Administration of an Inhibitor of HDAC and an mTOR Inhibitor
WO2009086012A1 (en) 2007-12-20 2009-07-09 Curis, Inc. Aurora inhibitors containing a zinc binding moiety
WO2010008847A2 (en) 2008-06-24 2010-01-21 Takeda Pharmaceutical Company Limited Pi3k/m tor inhibitors
WO2009155659A1 (en) 2008-06-27 2009-12-30 The University Of Queensland Combination therapy
US8196911B2 (en) 2008-10-27 2012-06-12 Honda Motor Co., Ltd. Adjustable rate subframe mount
AU2010203512C1 (en) 2009-01-08 2013-10-17 Curis, Inc. Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
US8741295B2 (en) 2009-02-09 2014-06-03 Universite De La Mediterranee PD-1 antibodies and PD-L1 antibodies and uses thereof
CA2753285A1 (en) 2009-03-12 2010-09-16 Genentech, Inc. Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
KR101489045B1 (ko) 2009-10-12 2015-02-02 에프. 호프만-라 로슈 아게 Pi3k 억제자 및 mek 억제자의 조합
AU2011239537A1 (en) * 2010-04-16 2012-11-15 Curis, Inc. Treatment of cancers having K-ras mutations
SG10201602569RA (en) * 2011-04-01 2016-05-30 Curis Inc Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
US20130102595A1 (en) 2011-04-15 2013-04-25 Curis, Inc. Treatment of cancers having k-ras mutations
SG10201606284UA (en) 2011-08-01 2016-09-29 Genentech Inc Methods Of Treating Cancer Using Pd-1 Axis Binding Antagonists And Mek Inhibitors
CN114796501A (zh) 2015-06-25 2022-07-29 免疫医疗公司 抗体与治疗剂的组合治疗癌症的方法
WO2018085342A1 (en) * 2016-11-02 2018-05-11 Curis, Inc. Combination therapy with a phosphoinositide 3-kinase inhibitor with a zinc binding moiety

Similar Documents

Publication Publication Date Title
JP2016188255A5 (show.php)
CN105473579A (zh) 布瑞哌唑、其关键中间体及其盐的制备方法
HRP20191091T1 (hr) Inhibitor fosfoinozitid-3-kinaze s ostatkom koji se veže na cink
CN109311892A (zh) 手性吡咯并嘧啶化合物的制备方法
JP2009543861A5 (show.php)
JP2018526340A5 (show.php)
JP2015129106A5 (show.php)
JP2017505801A5 (show.php)
JP2013520495A5 (show.php)
JP2018522018A5 (show.php)
MX2015001114A (es) Metodo para producir 4-[5-(piridin-4-il)-1h-1,2,4-triazol-3-il] piridina-2-carbonitrilo e intermediario del mismo.
JP2005538088A5 (show.php)
JP2013100237A5 (show.php)
JP2015523337A5 (show.php)
JP2013234194A5 (show.php)
JP2016535033A5 (show.php)
JP2017533926A5 (show.php)
JP2013241421A5 (show.php)
JP2015535210A5 (show.php)
JP2014009330A5 (show.php)
CN203990648U (zh) 一种化工试剂反应釜
CN105358529A8 (zh) 一种合成阿哌沙班重要中间体的新方法
JP2015508069A5 (show.php)
WO2017215019A1 (zh) 一种合成雷迪帕韦手性中间体的新方法
JP2010535185A5 (show.php)